Explore Latest News .

Find all the latest news on Paul Peter Tak, as well as a comprehensive list of his past interviews and features. Paul Peter’s work in immunology and the pharmaceutical industry has led him to be featured in both business and medicine specific publications.

During his time at GlaxoSmithKline, Paul Peter gave a number of interviews and briefs, including one with the Biochemical Society in 2017. In this insightful interview, Paul Peter outlined what the GSK Immunology Network was and its impact on this important area of research.

In December 2020, Paul Peter Tak spoke with Eleanor Malone, from Scrip, about the work Candel Therapeutics was undertaking in the field of cancer immunotherapy and the companies ambitious future. Paul Peter has also had more broad discussions around his career and what inspires him, such as his interview with Stephanie Sutton for The Medicine Maker, in 2020.   

Candel Therapeutics appoints Diem Nguyen, Ph.D., M.B.A., to Board of Directors

The results of this first-in-human study of CAN-3110 demonstrate a median overall survival that was substantially longer than the six to nine months typically observed in recurrent high-grade glioma as well as a favorable safety profile.…

Candel Therapeutics at the Jefferies Virtual Healthcare Conference 2021

Candel Therapeutics, Inc., a late clinical stage biopharmaceutical company developing novel oncolytic viral immunotherapies, today announced that Paul Peter Tak, M.D. Ph.D., President and Chief Exec…

Carrie Cox joins the Candel team and lead our Board of Directors

We are delighted to have Carrie Cox join the Candel team and lead our Board of Directors. Her strategic insights will be key as we advance our late stage pipeline of agents with the potential to bec…

Prof Paul Peter Tak: Rheumatology, Real Impact and Comfort Zones

In this week’s podcast episode, Professor Paul Peter Tak joins us as we delve into the multifaceted facets of his life, starting from his formative years growing up in the Netherlands. Professo…
Paul Peter Tak

© Paul Peter Tak.
All rights reserved.